<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Meat <z:chebi fb="1" ids="25435">mutagens</z:chebi>, including heterocyclic <z:chebi fb="39" ids="32952">amines</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HCAs</z:e>), <z:chebi fb="6" ids="33848">polycyclic aromatic hydrocarbons</z:chebi> (<z:chebi fb="11" ids="104011,31204,33848,53305">PAHs</z:chebi>) and N-<z:chebi fb="1" ids="35800">nitroso compounds</z:chebi> (NOCs), may be involved in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> depending on their activation or detoxification by phase I and II <z:chebi fb="0" ids="35703">xenobiotic</z:chebi> metabolizing enzymes (XME) </plain></SENT>
<SENT sid="1" pm="."><plain>Using unconditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI), we examined the intake of five meat <z:chebi fb="1" ids="25435">mutagens</z:chebi> and &gt;300 single nucleotide polymorphisms (SNPs) in 18 XME genes in relation to advanced colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> (1205 cases and 1387 controls) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (370 cases and 401 controls) within the Prostate, Lung, Colorectal, and <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">Ovarian Cancer</z:e> Screening Trial </plain></SENT>
<SENT sid="2" pm="."><plain>Dietary intake of meat <z:chebi fb="1" ids="25435">mutagens</z:chebi> was assessed using a food frequency questionnaire with a detailed meat-cooking module </plain></SENT>
<SENT sid="3" pm="."><plain>An interaction was observed between 2-amino-3,8-dimethylimidazo[4,5-f]<z:chebi fb="0" ids="36616">quinoxaline</z:chebi> (MeIQx) intake and the NAT1 polymorphism rs6586714 in the <z:mpath ids='MPATH_270'>adenoma</z:mpath> study (P(interaction) = 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Among individuals carrying a GG genotype, high MeIQx intake was associated with a 43% increased risk of <z:mpath ids='MPATH_270'>adenoma</z:mpath> (95% CI 1.11-1.85, P(trend) = 0.07), whereas the reverse was observed among carriers of the A variant (OR = 0.50, 95% CI 0.30-0.84, P(trend) = 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we observed some suggestive (P &lt; 0.05) modifying effects for SNPs in other XME genes (UGT1A, CYP2E1, EPHX1, AHR and GSTM3), but these were not significant after adjustment for multiple testing </plain></SENT>
<SENT sid="6" pm="."><plain>This large and comprehensive study of XME genes, meat <z:chebi fb="1" ids="25435">mutagens</z:chebi> and the risk of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumours</z:e> found that a NAT1 polymorphism modified the association between MeIQx intake and colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> risk </plain></SENT>
</text></document>